OptimizeRx Corp — Director's Dealing 2022

Oct 3, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2022-10-01

Reporting Person: Besch Doug (Chief Product Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock	$50.99	2026-05-31	Stock Option (15000.0)		Direct

Footnotes

F1: The stock option vests in three equal annual installments beginning on June 1, 2022, which was the first anniversary of the date of grant.